Boston Trust Walden Corp Has $35.78 Million Stock Holdings in Marsh & McLennan Companies, Inc. $MMC

Boston Trust Walden Corp decreased its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC) by 8.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 177,555 shares of the financial services provider’s stock after selling 15,513 shares during the quarter. Boston Trust Walden Corp’s holdings in Marsh & McLennan Companies were worth $35,783,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of MMC. Norges Bank acquired a new stake in shares of Marsh & McLennan Companies in the second quarter worth $1,328,587,000. Valeo Financial Advisors LLC grew its position in Marsh & McLennan Companies by 48,212.9% in the 2nd quarter. Valeo Financial Advisors LLC now owns 2,629,187 shares of the financial services provider’s stock worth $574,845,000 after purchasing an additional 2,623,745 shares during the last quarter. Soundwatch Capital LLC bought a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth about $560,820,000. Mackenzie Financial Corp lifted its stake in shares of Marsh & McLennan Companies by 212.6% in the second quarter. Mackenzie Financial Corp now owns 2,285,194 shares of the financial services provider’s stock valued at $499,635,000 after buying an additional 1,554,114 shares during the period. Finally, Amundi grew its position in Marsh & McLennan Companies by 89.2% during the second quarter. Amundi now owns 2,892,576 shares of the financial services provider’s stock worth $615,309,000 after buying an additional 1,363,706 shares in the last quarter. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh & McLennan Companies Stock Up 0.3%

MMC opened at $187.53 on Tuesday. The firm has a market cap of $91.87 billion, a price-to-earnings ratio of 22.49, a PEG ratio of 3.21 and a beta of 0.75. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.12 and a current ratio of 1.12. The firm’s 50-day simple moving average is $182.99 and its 200-day simple moving average is $198.13. Marsh & McLennan Companies, Inc. has a twelve month low of $174.18 and a twelve month high of $248.00.

Marsh & McLennan Companies (NYSE:MMC) last released its quarterly earnings results on Thursday, October 16th. The financial services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.78 by $0.07. The firm had revenue of $6.35 billion for the quarter, compared to analyst estimates of $6.34 billion. Marsh & McLennan Companies had a net margin of 15.60% and a return on equity of 31.79%. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.63 earnings per share. Equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO John Q. Doyle sold 21,079 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $182.22, for a total transaction of $3,841,015.38. Following the completion of the sale, the chief executive officer directly owned 87,681 shares of the company’s stock, valued at $15,977,231.82. This trade represents a 19.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.35% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Marsh & McLennan Companies in a research report on Friday, October 31st. JPMorgan Chase & Co. raised Marsh & McLennan Companies from a “neutral” rating to an “overweight” rating and reduced their target price for the stock from $248.00 to $242.00 in a research report on Thursday, October 9th. Wells Fargo & Company lowered their price target on shares of Marsh & McLennan Companies from $222.00 to $212.00 and set an “equal weight” rating on the stock in a report on Friday, October 17th. Morgan Stanley reduced their price objective on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an “equal weight” rating for the company in a report on Tuesday, October 7th. Finally, Bank of America reissued an “underperform” rating and issued a $181.00 target price (down previously from $243.00) on shares of Marsh & McLennan Companies in a research note on Monday, November 3rd. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $222.35.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.